Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT06629818
Status:
RECRUITING
Last Update Posted:
2025-06-03
First Post:
2024-10-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
Sponsor:
Peking Union Medical College Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-03
First Submit QC Date:
None
Study First Post Date:
2024-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-01
Last Update Post Date:
2025-06-03
Last Update Post Date Type:
ACTUAL